Antonion Zapatero Gaviria | Biomedical Sciences | Best Paper Award

Prof. Dr. Antonion Zapatero Gaviria | Biomedical Sciences | Best Paper Award

Jefe de Servicio de Medicina Interna | Hospital Universitario de Fuenlabrada | Spain

Dr. Antonio Zapatero-Gaviria is a distinguished Spanish physician, academic, and public health leader recognized for his outstanding contributions to internal medicine, clinical management, and healthcare policy. He currently serves as Professor of Medicine at the Universidad Rey Juan Carlos and has held pivotal leadership positions within the Spanish healthcare system, including Vice-Minister of Public Health and COVID-19 Response for the Community of Madrid, and Director of the IFEMA Field Hospital during the COVID-19 emergency in 2020. With over four decades of medical and academic experience, Dr. Zapatero-Gaviria has made significant contributions to the advancement of internal medicine and clinical governance. He has authored or co-authored more than 148 scientific publications, garnering over 2,200 citations and achieving an h-index of 27 according to Scopus. His research spans a wide range of topics including infectious diseases, COVID-19 pathophysiology, diabetes care, and health systems management, reflecting both national and international collaborations. A former President of the Spanish Society of Internal Medicine (SEMI) and President of the Federation of Spanish Medical Scientific Associations (FACME), he has played a decisive role in shaping medical standards, professional development, and evidence-based healthcare in Spain. His academic excellence is reflected in three research merit recognitions by ANECA and his induction as a full member of the Real Academia Europea de Doctores in 2024. Dr. Zapatero-Gaviria’s work integrates scientific rigor, leadership in health crisis management, and commitment to the modernization of medical care. His influence extends beyond academia, embodying a model of physician-leadership that bridges clinical excellence, policy innovation, and public service for the betterment of healthcare systems and patient outcomes.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Pairo-Castineira, E., Rawlik, K., Bretherick, A. D., Qi, T., Wu, Y., Nassiri, I., … Zapatero-Gaviria, A. (2023). GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature, 617(7962), 764–768. https://doi.org/10.1038/s41586-023-06034-3 — 183 citations

  2. Barba, R., Losa, J. E., Velasco, M., Guijarro, C., de Casasola, G. G., & Zapatero, A. (2006). Mortality among adult patients admitted to the hospital on weekends. European Journal of Internal Medicine, 17(5), 322–324. https://doi.org/10.1016/j.ejim.2006.03.008 — 163 citations

  3. Sanchez-Vazquez, R., Guío-Carrión, A., Zapatero-Gaviria, A., Martínez, P., … (2021). Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY), 13(1), 1–14. https://doi.org/10.18632/aging.202476 — 122 citations

  4. Zapatero, A., Barba, R., Ruiz, J., Losa, J. E., Plaza, S., Canora, J., & Marco, J. (2013). Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. Journal of Human Nutrition and Dietetics, 26(Suppl. 1), 16–22. https://doi.org/10.1111/jhn.12044 — 116 citations

  5. Marco, J., Barba, R., Zapatero, A., Matía, P., Plaza, S., Losa, J. E., Canora, J., … (2011). Prevalence of the notification of malnutrition in the departments of internal medicine and its prognostic implications. Clinical Nutrition, 30(4), 450–454. https://doi.org/10.1016/j.clnu.2011.01.008 — 103 citations

Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Dr. Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Professor | Mahatma Gandhi Medical College & Hospital | India

Dr. E. Rajni Sabharwal, MD in Microbiology, is a leading researcher in clinical microbiology, antimicrobial resistance (AMR), and infection control. Her research focuses on emerging multidrug-resistant and extensively drug-resistant organisms, epidemiology of hospital-acquired infections, and antimicrobial susceptibility patterns in critical clinical settings, including urinary tract and bloodstream infections. She actively contributes to national multicentric studies on AMR surveillance and the implementation of antimicrobial and diagnostic stewardship programs, integrating One Health approaches. Dr. Sabharwal’s work encompasses molecular characterization of pathogens, synergy testing of novel antibiotic combinations, biofilm studies, and evaluation of rapid diagnostic tools to optimize patient management. Her publications address Gram-negative resistance, carbapenem-resistant Enterobacterales, Stenotrophomonas and MRSA infections, fungal pathogens, and empirical management strategies in tertiary care hospitals. She also investigates the role of immunotherapeutic interventions, such as SPAG9-primed dendritic cell-based vaccines, in gallbladder cancer. With expertise in epidemiological research, laboratory diagnostics, and clinical trial design, she has advanced knowledge on antimicrobial stewardship and resistance mitigation. Through workshops, symposia, and mentorship, Dr. Sabharwal promotes evidence-based practices, bridging clinical microbiology with public health strategies to combat AMR and improve patient outcomes, establishing her as a prominent contributor to infectious disease research and translational microbiology. (210 citations by ; 36 Documents; h-index: 8).

Profiles: Google scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Sabharwal, E. R. (2012). Antibiotic susceptibility patterns of uropathogens in obstetric patients. North American Journal of Medical Sciences, 4(7), 316. Citations: 106

  2. Sabharwal, E. R., & Sharma, R. (2015). Fosfomycin: An alternative therapy for the treatment of UTI amidst escalating antimicrobial resistance. Journal of Clinical and Diagnostic Research, 9(12), DC06–DC09. Citations: 48

  3. Sabharwal, E. R., & Sharma, R. (2015). Estimation of microbial air contamination by settle plate method: Are we within acceptable limit? Scholars Academic Journal of Biosciences, 3(8), 703–707. Citations: 15

  4. Sabharwal, E. R. (2010). Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian Journal of Pathology and Microbiology, 53(2), 387–388. Citations: 14

  5. Jain, M., Sabharwal, E. R., & Srivastava, D. (2016). Practices of health care personnel regarding occupational exposure. Journal of Clinical and Diagnostic Research, 10(11), DC14–DC17. Citations: 12